Terms: = Liver cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16
129 results:
1. Efficacy and safety of drug-eluting bead transarterial chemoembolization (DEB-TACE) combined with tyrosine kinase inhibitors (TKIs) in patients with unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis.
Ji J; Zhang Z; Hou Z; Qiu G; Mi S; Jin Z; Huang J
Clin Res Hepatol Gastroenterol; 2024 Apr; 48(4):102313. PubMed ID: 38453011
[TBL] [Abstract] [Full Text] [Related]
2. Application of the Left Lateral Decubitus Position in Laparoscopic Right Posterior Lobectomy.
Huang DF; Xu JB; Du YM; Wang YB; Zhou DH
Surg Laparosc Endosc Percutan Tech; 2024 Apr; 34(2):178-184. PubMed ID: 38417113
[TBL] [Abstract] [Full Text] [Related]
3. Mineral Intake and Cardiovascular Disease, cancer, and All-Cause Mortality: Findings from the Golestan Cohort Study.
Yazdanpanah MH; Sharafkhah M; Poustchi H; Etemadi A; Sheikh M; Kamangar F; Pourshams A; Boffetta P; Dawsey SM; Abnet CC; Malekzadeh R; Hashemian M
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337629
[TBL] [Abstract] [Full Text] [Related]
4. TBACkp: HER2 expression status classification network focusing on intrinsic subenvironmental characteristics of breast cancer liver metastases.
Yang K; Song J; Liu M; Xue L; Liu S; Yin X; Liu K
Comput Biol Med; 2024 Mar; 170():108002. PubMed ID: 38277921
[TBL] [Abstract] [Full Text] [Related]
5. Survival analysis of palliative radiotherapy in patients with HER-2+ metastatic breast cancer.
Li X; Zhong X; Xu H; Wang J; Liu X; Wang Y; He L; Ma J; Li G; Liu L
Front Endocrinol (Lausanne); 2023; 14():1305429. PubMed ID: 38260126
[TBL] [Abstract] [Full Text] [Related]
6. Survival analysis of patients with extrahepatic cholangiocarcinoma: a nomogram for clinical and MRI features.
Zeng Y; Wang X; Wu J; Wang L; Shi F; Shu J
BMC Med Imaging; 2024 Jan; 24(1):7. PubMed ID: 38166729
[TBL] [Abstract] [Full Text] [Related]
7. Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study.
Raverdy V; Chatelain E; Lasailly G; Caiazzo R; Vandel J; Verkindt H; Marciniak C; Legendre B; Bauvin P; Oukhouya-Daoud N; Baud G; Chetboun M; Vantyghem MC; Gnemmi V; Leteurtre E; Staels B; Lefebvre P; Mathurin P; Marot G; Pattou F
Obesity (Silver Spring); 2023 Dec; 31(12):3066-3076. PubMed ID: 37987186
[TBL] [Abstract] [Full Text] [Related]
8. Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma.
Zhao Y; Zhang J; Wang N; Xu Q; Liu Y; Liu J; Zhang Q; Zhang X; Chen A; Chen L; Sheng L; Song Q; Wang F; Guo Y; Liu A
BMC Cancer; 2023 Oct; 23(1):1026. PubMed ID: 37875815
[TBL] [Abstract] [Full Text] [Related]
9. Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma.
Zou H; Xue Y; Chen X; Lai Y; Yao D; Ung COL; Hu H
PLoS One; 2023; 18(10):e0292239. PubMed ID: 37796814
[TBL] [Abstract] [Full Text] [Related]
10. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a model to predict the risk of distant metastases from hepatocellular carcinoma: a real-world retrospective study.
Shao G; Fan Z; Qiu W; Lv G
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16489-16499. PubMed ID: 37712961
[TBL] [Abstract] [Full Text] [Related]
12. Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National cancer Database.
Endo Y; Sasaki K; Munir MM; Woldesenbet S; Resende V; Rawicz-Pruszyński K; Waqar U; Mavani P; Katayama E; Yang J; Khalil M; Khan MMM; Kitago M; Pawlik TM
J Gastrointest Surg; 2023 Oct; 27(10):2103-2113. PubMed ID: 37674099
[TBL] [Abstract] [Full Text] [Related]
13. Impact of perceived ease of use, organizational support mechanism, and industry competitive pressure on physicians' use of liver cancer screening technology in medical alliances.
Lu J; Deng Q; Chen Y; Liu W
Front Public Health; 2023; 11():1174334. PubMed ID: 37601185
[TBL] [Abstract] [Full Text] [Related]
14. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
15. cancer Statistics in Pakistan From 1994 to 2021: Data From cancer Registry.
Tufail M; Wu C
JCO Clin Cancer Inform; 2023 Jul; 7():e2200142. PubMed ID: 37450777
[TBL] [Abstract] [Full Text] [Related]
16. A gadoxetic-acid enhancement flux analysis of small liver nodules (≤2 cm) in patients at high risk of hepatocellular carcinoma.
Chen H; Wang J; Guo T; Ye T; Wan J; Sun P; Pan F; Yang L
Eur J Radiol; 2023 Aug; 165():110911. PubMed ID: 37300937
[TBL] [Abstract] [Full Text] [Related]
17. liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
[TBL] [Abstract] [Full Text] [Related]
18. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
[TBL] [Abstract] [Full Text] [Related]
19. Prediction of microvascular invasion in combined hepatocellular-cholangiocarcinoma based on preoperative contrast-enhanced CT and clinical data.
Zhang J; Dong W; Li Y; Fu J; Jia N
Eur J Radiol; 2023 Jun; 163():110839. PubMed ID: 37121101
[TBL] [Abstract] [Full Text] [Related]
20. Research on Predicting the Occurrence of Hepatocellular Carcinoma Based on Notch Signal-Related Genes Using Machine Learning Algorithms.
Zhou D; Cao S; Xie H
Turk J Gastroenterol; 2023 Jul; 34(7):760-770. PubMed ID: 37051625
[TBL] [Abstract] [Full Text] [Related]
[Next]
